Spexotras

trametinib dimethyl sulfoxide · Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Spexotras, covering 2025-11-03 to 2025-11-03. Get the full timeline:

Most recent: EMA Authorised: Spexotras (trametinib dimethyl sulfoxide) — Novartis Europharm Limited